These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 14630716)
1. An octamer motif is required for activation of the inducible nitric oxide synthase promoter in pancreatic beta-cells. Darville MI; Terryn S; Eizirik DL Endocrinology; 2004 Mar; 145(3):1130-6. PubMed ID: 14630716 [TBL] [Abstract][Full Text] [Related]
2. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Darville MI; Eizirik DL Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation. Kim MJ; Ryu GR; Kang JH; Sim SS; Min DS; Rhie DJ; Yoon SH; Hahn SJ; Jeong IK; Hong KJ; Kim MS; Jo YH Biochem Pharmacol; 2004 Nov; 68(9):1775-85. PubMed ID: 15450943 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. Kwon G; Corbett JA; Rodi CP; Sullivan P; McDaniel ML Endocrinology; 1995 Nov; 136(11):4790-5. PubMed ID: 7588208 [TBL] [Abstract][Full Text] [Related]
6. High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer. Perrella MA; Pellacani A; Wiesel P; Chin MT; Foster LC; Ibanez M; Hsieh CM; Reeves R; Yet SF; Lee ME J Biol Chem; 1999 Mar; 274(13):9045-52. PubMed ID: 10085153 [TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production. Flodström M; Eizirik DL Endocrinology; 1997 Jul; 138(7):2747-53. PubMed ID: 9202213 [TBL] [Abstract][Full Text] [Related]
8. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Ganster RW; Taylor BS; Shao L; Geller DA Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8638-43. PubMed ID: 11438703 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells. Eberhardt W; Plüss C; Hummel R; Pfeilschifter J J Immunol; 1998 May; 160(10):4961-9. PubMed ID: 9590244 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of iNOS induction by IL-1 beta and IFN-gamma in rat aortic smooth muscle cells. Teng X; Zhang H; Snead C; Catravas JD Am J Physiol Cell Physiol; 2002 Jan; 282(1):C144-52. PubMed ID: 11742807 [TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B. Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701 [TBL] [Abstract][Full Text] [Related]
12. IL-1beta induces serine protease inhibitor 3 (SPI-3) gene expression in rat pancreatic beta-cells. Detection by differential display of messenger RNA. Chen MC; Schuit F; Pipeleers DG; Eizirik DL Cytokine; 1999 Nov; 11(11):856-62. PubMed ID: 10547273 [TBL] [Abstract][Full Text] [Related]
13. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691 [TBL] [Abstract][Full Text] [Related]
14. Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells. Azevedo-Martins AK; Lortz S; Lenzen S; Curi R; Eizirik DL; Tiedge M Diabetes; 2003 Jan; 52(1):93-101. PubMed ID: 12502498 [TBL] [Abstract][Full Text] [Related]
15. IL-6 induction of protein-DNA complexes via a novel regulatory region of the inducible nitric oxide synthase gene promoter: role of octamer binding proteins. Sawada T; Falk LA; Rao P; Murphy WJ; Pluznik DH J Immunol; 1997 Jun; 158(11):5267-76. PubMed ID: 9164945 [TBL] [Abstract][Full Text] [Related]
16. cAMP inhibits inducible nitric oxide synthase expression and NF-kappaB-binding activity in cultured rat hepatocytes. Harbrecht BG; Taylor BS; Xu Z; Ramalakshmi S; Ganster RW; Geller DA J Surg Res; 2001 Aug; 99(2):258-64. PubMed ID: 11469895 [TBL] [Abstract][Full Text] [Related]
17. A reverse nuclear factor-kappaB element in the rat type II nitric oxide synthase promoter mediates the induction by interleukin-1beta and interferon-gamma in rat aortic smooth muscle cells. Teng X; Zhang H; Snead C; Catravas JD Gen Pharmacol; 2000 Jan; 34(1):9-16. PubMed ID: 10793263 [TBL] [Abstract][Full Text] [Related]
18. Octamer motif is required for the NF-kappaB-mediated induction of the inducible nitric oxide synthase gene expression in RAW 264.7 macrophages. Kim YM; Ko CB; Park YP; Kim YJ; Paik SG Mol Cells; 1999 Feb; 9(1):99-109. PubMed ID: 10102579 [TBL] [Abstract][Full Text] [Related]
19. Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: The role of NF-kappa B-repressing factor (NRF) in basal repression of the hiNOS gene. Feng X; Guo Z; Nourbakhsh M; Hauser H; Ganster R; Shao L; Geller DA Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14212-7. PubMed ID: 12381793 [TBL] [Abstract][Full Text] [Related]
20. Heat shock inhibits cytokine-induced nitric oxide synthase expression by rat and human islets. Scarim AL; Heitmeier MR; Corbett JA Endocrinology; 1998 Dec; 139(12):5050-7. PubMed ID: 9832444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]